The Use of Calcimimetics for the Treatment of Secondary Hyperparathyroidism: A 10 Year Evidence Review

E-ISSN： 1525-139x|28|5|497-507

ISSN： 0894-0959

Source： SEMINARS IN DIALYSIS, Vol.28, Iss.5, 2015-09, pp. : 497-507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evidence for the use of demeclocycline in the treatment of hyponatraemia secondary to SIADH: a systematic review

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (ELECTRONIC), Vol. 69, Iss. 12, 2015-12 ,pp. : 1396-1417

John Wiley & Sons Inc

Access to resources Recommend Favorite

Relationship between Reductions in Parathyroid Hormone and Serum Phosphorus during the Management of Secondary Hyperparathyroidism with Calcimimetics in Hemodialysis Patients

Nephron Clin Pract, Vol. 121, Iss. 3-4, 2012-11 ,pp. : c124-c130

Karger

Access to resources Recommend Favorite

Effective use of cinacalcet for the treatment of secondary hyperparathyroidism in Austrian dialysis patients – Results of the Austrian cohort of the ECHO study

By Zitt Emanuel

Wiener klinische Wochenschrift, Vol. 123, Iss. 1-2, 2011-01 ,pp. : 45-52

Springer Publishing Company

Access to resources Recommend Favorite

Role of surgery in the treatment of renal secondary hyperparathyroidism

BRITISH JOURNAL OF SURGERY, Vol. 102, Iss. 4, 2015-03 ,pp. : 289-290

John Wiley & Sons Inc

Access to resources Recommend Favorite

Medical Treatment of Primary, Secondary, and Tertiary Hyperparathyroidism

Current Drug Safety, Vol. 6, Iss. 2, 2011-04 ,pp. : 108-113

Bentham Science Publishers

Access to resources Recommend Favorite